Pre- and post-analytical factors that may influence use of serum prostate specific antigen and its isoforms in a screening programme for prostate cancer.
Price
C P
CP
Department of Clinical Biochemistry, St. Bartholomew's & Royal London School of Medicine and Dentistry, UK. c.p.price@mds.qmw.ac.uk
Allard
J
J
Davies
G
G
Dawnay
A
A
Duffy
M J
MJ
France
M
M
Mandarino
G
G
Ward
A M
AM
Patel
B
B
Sibley
P
P
Sturgeon
C
C
D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D008297:Male; D008875:Middle Aged; D011467:Prostate / Q000473:pathology; D017430:Prostate-Specific Antigen / Q000097:blood* / Q000737:chemistry*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000175:diagnosis*; D020033:Protein Isoforms; D012016:Reference Values; D012680:Sensitivity and Specificity
D020033:Protein Isoforms; D017430:Prostate-Specific Antigen